Stahl Carsten, Beierlein Wolfram, Walker Tobias, Straub Andreas, Nagy Zolt, Knubben Karolin, Greiner Tim O, Lippert Michael, Czygan Gerald, Paule Stefan, Schweika Oliver, Kühlkamp Volker
Department of Cardiology, University of Tübingen, Germany.
J Cardiovasc Electrophysiol. 2007 Sep;18(9):985-90. doi: 10.1111/j.1540-8167.2007.00868.x. Epub 2007 Jun 6.
A large number of heart failure (HF) patients benefit from cardiac resynchronization therapy. Measurements of intrathoracic impedance (ITZ) by implantable devices correlate with intrathoracic fluid content and are used for monitoring lung edema formation in HF patients. However, intrathoracic fluid is only an indirect parameter of cardiac function. We hypothesized that changes in intracardiac impedance correlate with left ventricular (LV) volume changes. Therefore, measurements of intracardiac impedance between a right ventricular lead and a LV lead may be used to monitor long-term changes of LV function.
HF was successfully induced in nine mini-pigs by continuous high-rate pacing. Hemodynamic parameters as well as intracardiac impedance and ITZ were measured before HF induction and after 20 +/- 5 days of high-rate pacing. After the pacing period, we found a significant deterioration of hemodynamics, reflected by a reduction of ejection fraction from 71+/-11% to 48+/-7% and an increase of LV end diastolic pressure (EDP) from 12 +/- 4 mmHg to 26 +/- 8 mmHg. Worsening of cardiac function correlated with a significant >30% decrease of end diastolic intracardiac impedance, in accordance with a >20% increase of end diastolic volume (EDV). ITZ decreased by more than 8%. We observed a significant inverse correlation between end diastolic intracardiac impedance and EDP (r =-0.81, P < 0.001).
In this animal model, changes of intracardiac impedance revealed hemodynamic deterioration as reflected by EDV and EDP pressure. Thus, intracardiac impedance is a promising new application to monitor heart failure status within implantable devices.
大量心力衰竭(HF)患者受益于心脏再同步治疗。植入式设备测量的胸腔内阻抗(ITZ)与胸腔内液体含量相关,可用于监测HF患者肺水肿的形成。然而,胸腔内液体只是心功能的一个间接参数。我们假设心内阻抗的变化与左心室(LV)容积变化相关。因此,右心室导线和LV导线之间的心内阻抗测量可用于监测LV功能的长期变化。
通过持续高频率起搏成功诱导9只小型猪发生HF。在诱导HF前以及高频率起搏20±5天后测量血流动力学参数以及心内阻抗和ITZ。起搏期结束后,我们发现血流动力学显著恶化,表现为射血分数从71±11%降至48±7%,LV舒张末期压力(EDP)从12±4 mmHg升至26±8 mmHg。心功能恶化与舒张末期心内阻抗显著降低>30%相关,同时舒张末期容积(EDV)增加>20%。ITZ下降超过8%。我们观察到舒张末期心内阻抗与EDP之间存在显著负相关(r = -0.81,P < 0.001)。
在这个动物模型中,心内阻抗的变化揭示了由EDV和EDP压力反映的血流动力学恶化。因此,心内阻抗是一种在植入式设备中监测心力衰竭状态的有前景的新应用。